The diagnostic significance of circulating lncRNA ADAMTS9-AS2 tumor biomarker in non-small cell lung cancer among the Egyptian population

Faculty Medicine Year: 2021
Type of Publication: ZU Hosted Pages:
Authors:
Journal: J Gene Medicine wiley Volume:
Keywords : , diagnostic significance , circulating lncRNA ADAMTS9-AS2 tumor biomarker    
Abstract:
Background: Long non-coding RNA ADAM metallopeptidase with thrombospondin type 1 motif, 9 antisense RNA 2 (ADAMTS9-AS2) was recognized as a novel tumor suppressor and plays an important role in the initiation and progression of malignant behavior in human cancers, although its plasma expression and clinical value in patients with non-small cell lung cancer (NSCLC) remain unknown. We aimed to analyze the diagnostic role of ADAMTS9-AS2 and cytokeratin 19 fragmentation antigen (CYFRA 21-1) in NSCLC. Methods: The present study included 80 control subjects, 80 patients with benign lung lesion and 80 NSCLC patients. The expression of ADAMTS9-AS2 in the tissue and plasma was detected by a real-time polymerase chain reaction. Serum CYFRA 21-1 was analyzed using an enzyme-linked immunosorbent assay. Results: In comparison with benign lung lesion and controls, tissue and plasma ADAMTS9-AS2 expression were significantly down-regulated in NSCLC (p < 0.001). Decreased ADAMTS9-AS2 expression was associated with TNM stages in NSCLC patients (p < 0.001). Up-regulation of CYFRA 21-1 was reported among NSCLC patients and it was associated with TNM staging. Tissue and plasma ADAMTS9-AS2 expression levels were the predicting factors for NSCLC and they both correlated negatively with CYFRA 21-1 levels. Plasma ADAMTS9-AS2 levels had a significant positive correlation with their tumor tissue levels. Plasma ADAMTS9-AS2 showed a higher sensitivity (95%) and specificity (99.1%) in the diagnosis of NSCLC than CYFRA 21-1 (61.3% sensitivity and 60% specificity). Conclusions: Our results suggested that decreased plasma ADAMTS9-AS2 expression might act as a novel non-invasive tumor biomarker in NSCLC diagnosis. Furthermore, plasma ADAMTS9-AS2 might predict aggressive tumor behavior.
   
     
 
       

Author Related Publications

  • Nearmeen Mohammed Rashad Ahmmad, "Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis", wiley, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "Osteoprotegerin expression and serum values in obese women with type 2 diabetes mellitus", springer, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "nterferon-gamma Expression Profile as Diagnostic Signatures of Unexplained Infertility in Female Patients Suffer from Hashimoto's Thyroiditis", Tehran University of Medical Sciences, 2021 More
  • Nearmeen Mohammed Rashad Ahmmad, "Association of miRNA − 320 expression level and its target gene endothelin-1 with the susceptibility and clinical features of polycystic ovary syndrome", BMC, 2019 More
  • Nearmeen Mohammed Rashad Ahmmad, "ntercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome", BMC, 2019 More

Department Related Publications

  • Mohammed Sallam Suleiman Saad, "Role of MicroRNA 126 in Screening, Diagnosis, and Prognosis of Diabetic Patients in Egypt", wiley, 2016 More
  • Mohamed Essam El Din Ahmd, "Effect of aerobic exercises on blood coagulation and fibrinolytic system in type 2 diabetic patients", International Journal of Advanced research (2015), Volume 3, Issue 5,64-70, 2015 More
  • Nafisa Mohamed KamalElDin, "Prevalence and effect of SEN virus in hemodialysis patients in Zagazig university nephrology unit", on line, 2016 More
  • Huda Abdul Aziz Hadi Ahmad, "Evaluation of Some Non Invasive Predictors for Presence of Esophageal Varices in Patients with Compensated HCV Positive Cirrhosis", International Journal of Science and Research (IJSR), 2016 More
  • Ayman Abdalrahman Mohamed Nasrllah, "Microalbuminurea Screening and Risk factors in adolescents with type 1 Diabetes Mellitus In Zagazig University Hospital n", London, 2012 More
Tweet